Skip to main content

Table 1 Baseline characteristics of the patients

From: Risk factors for increased immune reconstitution in response to Mycobacterium tuberculosis antigens in tuberculosis HIV-infected, antiretroviral-naïve patients

Characteristic Included
N = 61
Excluded
N =27
P-value
Age (Year) and median (IQR) 37 39 0.32
Gender, n (%)    0.21
 Male 49(80) 25(93)  
 Female 12(20) 2(7)  
Site of tuberculosis, n (%)    0.93
 Pulmonary 27(44) 13(48)  
 Disseminated 29(48) 12(44)  
 Extrapulmonary 5(8) 2(7)  
Efavirenz dose, n (%)    0.5
 600 mg 33(54) 12(44)  
 800 mg 28(46) 15(56)  
IRIS, n (%)    0.1
 No 54(88.52) 27(100)  
 Yes 7(11.48) 0 (0)  
CD4, n(%)    0.82
 < 200 cells/mm3 41(67) 17(63)  
 ≥ 200 cells/mm3 20(33) 10(37)  
CD4, median (IQR) 141.08(36–234) 162.74(71–227.5) 0.38
 < 200 cells/mm3 62(31–98) 89(34–130)  
 ≥ 200 cells/mm3 302.6(234.8–355.2) 288(227.2–308)  
HIV-1 viral load (copies/ml), n (%)    1
 ≤ 30,000 14(23) 6(22)  
 > 30,001 47(77) 21(78)  
  1. n number of case, IRIS Immune Reconstitution Inflammatory Syndrome, IQR Interquartile Range